BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Reauthorization of the Biosimilar User Fee Act\; Public Meeti
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-19660-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20261125
DTEND;VALUE=DATE:20261126
SUMMARY:FDA comments close: Reauthorization of the Biosimilar User Fee Act
 \; Public Meeting\; Request for Comments
DESCRIPTION:Notice. Federal Register 2026-19660. Docket FDA-2015-N-3326. D
 etails: https://docket-clock.pages.dev/doc/2026-19660/ Official: https://
 www.federalregister.gov/documents/2026/09/25/2026-19660/reauthorization-o
 f-the-biosimilar-user-fee-act-public-meeting-request-for-comments
URL:https://www.federalregister.gov/documents/2026/09/25/2026-19660/reauth
 orization-of-the-biosimilar-user-fee-act-public-meeting-request-for-comme
 nts
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR